The Comparative Pathobiology Group has focused much of its research on defining the pathogenesis of disorders affecting the reproductive tract of humans and rodents and assessing the role of environmental, endogenous and growth factors on the growth and induction of these disorders. In understating the role of proliferation in human uterine leiomyoma (fibroid) growth, we have found that both positive and negative regulators of apoptosis are not differentially expressed in fibroids compared to normal myometria, and that altered apoptosis does not appear to play a significant role in the development of these tumors. Our studies show that cell proliferation may be the most significant contributor to fibroid growth, although, it appears to be phasic, does not correlate with tumor size, and is autonomous for each tumor within a uterus. In studies addressing the role of growth factors in the pathogenesis of fibroids, we have found that IGF-I is overexpressed in fibroids compared to normal myometria during the proliferative phase of the menstrual cycle and that the IGF-I receptor is activated. These studies will help to define some of the basic biological and molecular pathways important in fibroid growth, which can then be applied to developing alternative noninvasive treatment regimens for fibroids. In vitro model systems for studying fibroids are limited in that human derived leiomyoma cells grow poorly in culture. We have overcome this obstacle by development of hTERT (human telomerase) immortalized uterine leiomyoma and myometrial cell lines. These cells are being used to study leiomyoma tumorigenesis in a prospective manner. In determining the role of environmental agents in fibroid development we have found that in CD-1 mice prenatal and neonatal exposures to diethylstilbestrol (DES) results in uterine leiomyomas similar to fibroids observed in women. Also, the phytoestrogen, genistein, can be stimulatory or inhibitory to uterine leiomyoma cell growth depending on its concentration.

Project Start
Project End
Budget Start
Budget End
Support Year
16
Fiscal Year
2009
Total Cost
$2,003,254
Indirect Cost
City
State
Country
Zip Code
Jokinen, M P; Morgan, D L; Price, H C et al. (2017) Immunohistochemical Characterization of Sarcomas in Trp53+/- Haploinsufficient Mice. Toxicol Pathol 45:774-785
Teng, Christina T; Hsieh, Jui-Hua; Zhao, Jinghua et al. (2017) Development of Novel Cell Lines for High-Throughput Screening to Detect Estrogen-Related Receptor Alpha Modulators. SLAS Discov 22:720-731
Hayes, A Wallace; Dixon, Darlene (2017) Cornerstones of Toxicology. Toxicol Pathol 45:57-63
Ramaiahgari, Sreenivasa C; Waidyanatha, Suramya; Dixon, Darlene et al. (2017) Three-dimensional (3D) HepaRG Spheroid Model with Physiologically-Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening. Toxicol Sci :
Sills, Robert; Brix, Amy; Cesta, Mark et al. (2017) NTP/NIEHS Global Contributions to Toxicologic Pathology. Toxicol Pathol 45:1035-1038
Irizarry, Armando R; Gropp, Kathryn E; Dixon, Darlene (2017) A Brief Overview of the STP 35th Annual Symposium on the Basis and Relevance of Variation in Toxicologic Responses. Toxicol Pathol 45:52-56
Ramaiahgari, Sreenivasa C; Waidyanatha, Suramya; Dixon, Darlene et al. (2017) Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening. Toxicol Sci 160:189-190
Yan, Yitang; Yu, Linda; Castro, Lysandra et al. (2017) ER?36, a variant of estrogen receptor ?, is predominantly localized in mitochondria of human uterine smooth muscle and leiomyoma cells. PLoS One 12:e0186078
Elmore, Susan A; Dixon, Darlene; Hailey, James R et al. (2016) Recommendations from the INHAND Apoptosis/Necrosis Working Group. Toxicol Pathol 44:173-88
Castro, Lysandra; Gao, Xioahua; Moore, Alicia B et al. (2016) A High Concentration of Genistein Induces Cell Death in Human Uterine Leiomyoma Cells by Autophagy. Expert Opin Environ Biol 5:

Showing the most recent 10 out of 48 publications